OICHARTS
8 AMThe 8 AM report →

RMD

ResMed Inc. · XNYS · 131 sessions on record
$221.10▼ −1.73 · −0.8%from $222.83 the session before · Sep 30, 2026 close · end of day
Open
$222.63
High
$224.04
Low
$220.00
Day's range
$4.01.8% of the previous close
VWAP
$221.72close −0.28% from it
Volume, shares
1.31M1.05× the 20-session average
Traded, $
$290.0M
Trades
22.3K59 shares per trade
Previous close
$222.83−1.73 to the close
Market cap
$31.89Bat the close of Sep 30
Day range27% of the way up
$220.00$224.04
52-week range66% of the way up
$180.27 Jun 2$242.40 Sep 1

−8.8% from the high · +23% from the low

Options

No listed options on RMD

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
RMD close over the last 126 sessions, with S&P 500 rebased to the first close182.82223.69264.56axis spans 45%S&P 500RMDApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 45 percent.

Quarterly results

consolidated · latest filed Aug 13, 2026 · SEC filings

Revenue $1.46B, +8.6% on a year earlier; profit $383.4M, +0.98% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of RMD on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Aug 13$1.46B▲ +8.6%$383.4M▲ +0.98%2.64▼ −1.0%S&P 500 −0.2% · −0.8 pp
Mar 2026filed May 1$1.43B▲ +11%$398.7M▲ +9.2%2.74▲ +2.2%S&P 500 −0.4% · +2.5 pp
Dec 2025filed May 1$1.42B▲ +11%$392.6M▲ +14%2.68▲ +2.2%S&P 500 −0.4% · +2.5 pp
Sep 2025filed May 1$1.34B▲ +9.1%$348.5M▲ +12%2.37▲ +2.2%S&P 500 −0.4% · +2.5 pp
Jun 2025filed Aug 8$1.35B▲ +10%$379.7M▲ +30%2.58—not reached
Mar 2025filed May 1$1.29B▲ +7.9%$365.0M▲ +21%2.48▲ +2.2%S&P 500 −0.4% · +2.5 pp
Dec 2024filed May 1$1.28B▲ +10%$344.6M▲ +65%2.34▲ +2.2%S&P 500 −0.4% · +2.5 pp
Sep 2024filed May 1$1.22B▲ +11%$311.4M▲ +42%2.11▲ +2.2%S&P 500 −0.4% · +2.5 pp
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of RMD on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY26to Jun 2026$5.65B▲ +9.8%$1.52B▲ +8.8%10.43
FY25to Jun 2025$5.15B▲ +9.8%$1.40B▲ +37%9.51
FY24to Jun 2024$4.69B▲ +11%$1.02B▲ +14%6.92
FY23to Jun 2023$4.22B▲ +18%$897.6M▲ +15%6.09
FY22to Jun 2022$3.58B▲ +12%$779.4M▲ +64%5.30

Fundamentals

consolidated · filings to Jun 2026 · close $221.10 on Sep 30

RMD trades at 21 times trailing earnings, 4.8 times book value, revenue +9.8% over twelve months, a 0.57% dividend yield, market cap $31.89B.

Valuation
Market cap
$31.89Bon Sep 30
Price to earnings
21consolidated · four quarters to Jun 2026
Trailing EPS
$10.43diluted · consolidated · four quarters to Jun 2026
Price to book
4.8consolidated · balance sheet to Jun 2026
Book value a share
$45.65consolidated · balance sheet to Jun 2026
Debt to equity
0.06borrowings over equity · consolidated · balance sheet to Jun 2026
Return on equity
24%trailing profit over average equity · consolidated
Dividend yield
0.57%$1.26 a share in 365 days
Price to sales
5.6market cap over revenue, four quarters to Jun 2026
Shares outstanding
144Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$5.65Bfour quarters to Jun 2026
Revenue growth, 12 months
▲ +9.8%against the twelve months before
Revenue 3-year CAGR
▲ +10%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$1.52Bfour quarters to Jun 2026
Profit growth, 12 months
▲ +8.8%against the twelve months before
Profit 3-year CAGR
▲ +19%trailing twelve months against the twelve months 3 years earlier · consolidated

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 140% of shares, BlackRock, Inc. the largest at 17%, VANGUARD CAPITAL MANAGEMENT LLC 13% and VANGUARD PORTFOLIO MANAGEMENT LLC 11%, as filed for the quarter to Jun 2026.

Held by 13F managers
140%of shares outstanding
Shares held
196M+1.9% on Mar 2026 among managers filing both
Managers holding
825878 a quarter earlier
Largest holder
17%BlackRock, Inc.
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of RMD
ManagerSharesOf outstandingValueChange on quarter
BlackRock, Inc.24.6M17%$4.80B+446K
VANGUARD CAPITAL MANAGEMENT LLC18.9M13%$3.69B+15.4K
VANGUARD PORTFOLIO MANAGEMENT LLC15.8M11%$3.08B+99.5K
STATE STREET CORP13.4M9.3%$2.60B+75.1K
GEODE CAPITAL MANAGEMENT, LLC8.7M6.0%$1.69B−1.11K
Bank of New York Mellon Corp8.4M5.8%$1.64B−1.46M
FIRST TRUST ADVISORS LP4.56M3.2%$888.1M+1.48M
Invesco Ltd.4.13M2.9%$804.3M+214K
MORGAN STANLEY3.86M2.7%$751.8M−1.52M
NORTHERN TRUST CORP3.39M2.4%$661.3M−58K
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

RMD insider trades
InsiderTradeSharesPriceHeld after
Farrell Michael J.Director,Officerexercised · Jun 8, 20264,991$146.34471,214
Farrell Michael J.Director,Officersold · Jun 8, 20264,991$193.96466,256
Rider Michael JOfficerwithheld for tax · Jun 1, 2026269$190.579,488
Farrell Michael J.Director,Officerexercised · May 7, 20264,991$146.34471,214
Farrell Michael J.Director,Officersold · May 7, 20264,991$207.82466,223
Farrell Michael J.Director,Officerexercised · Apr 7, 20264,991$146.34471,214
Farrell Michael J.Director,Officersold · Apr 7, 20264,991$225.50466,223
Sandercock BrettOfficersold · Apr 1, 20261,000$224.3183,495
FARRELL PETER CDirectorsold · Apr 1, 20262,000$225.0060,773
Farrell Michael J.Director,Officerexercised · Mar 9, 20264,991$146.34471,214

Corporate actions

exchange records

Nothing upcoming on record; the last was a dividend of $0.66 a share, ex-date Aug 20, 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in dollars a share, splits as ratios
Corporate actions of RMD, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord date
recent
Aug 20, 2026dividend$0.66—
May 14, 2026dividend$0.60—
Calendardividends by ex-date
Dividends in 365 days
$1.26a share · ex-dates inside the year
Last dividend
$0.66ex-date Aug 20, 2026

Price history

131 sessions on record · to Sep 30 · end of day

RMD is −4.4% over 20 sessions against the S&P 500's +0.1%, 8.8% below its 52-week high, realised volatility 19% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $RMD %S&P 500 %Difference pp
120 sessionssince Apr 9$227.99▼ −3.0%▲ +12%−15
60 sessionssince Jul 7$219.76▲ +0.61%▲ +2.0%−1.4
20 sessionssince Sep 1$231.35▼ −4.4%▲ +0.11%−4.5
5 sessionssince Sep 23$222.30▼ −0.54%▼ −0.67%+0.13
1 sessionsince Sep 29$222.84▼ −0.78%▼ −0.21%−0.57
Averages of the closeclose against each average
5-session average
$221.98close −0.40% from it
20-session average
$223.96close −1.3% from it
50-session average
$222.16close −0.48% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$5.22.3% of the close
Average day's range, 20
$4.82.2% of the close
Volume against 20 sessions
1.05×1.31M vs 1.27M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
19%≈ ±1.2% a session · moved more than that on 4 of 20
Realised volatility, 60
34%≈ ±2.1% a session · moved more than that on 18 of 60
Beta to S&P 500, 60
0.28moved with S&P 500 on 38 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
7 up · 13 downof 20
Last 60 sessions
28 up · 32 downof 60
Best session, 250
▲ +4.8%Aug 19
Worst session, 250
▼ −6.3%Jul 8

ResMed Inc. is held by

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 67% of reported volume on Sep 30, 2026, against 75% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
RMD daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 2026390K585K66.7%
Sep 29, 2026271K407K66.6%
Sep 28, 2026214K320K66.9%
Sep 25, 2026140K205K68.6%
Sep 24, 2026219K314K69.5%
Sep 23, 2026373K566K65.8%
Sep 22, 2026165K297K55.5%
Sep 21, 2026195K357K54.7%
Sep 18, 2026297K454K65.5%
Sep 17, 2026362K463K78.1%

Filings

SEC EDGAR · newest first
RMD SEC filings
FiledFormReport date
Sep 10, 20264Sep 8, 2026
Sep 8, 2026144—
Sep 4, 20264Sep 2, 2026
Sep 2, 2026144—
Sep 1, 20268-KAug 31, 2026
Aug 17, 20268-KAug 13, 2026
Aug 13, 202610-KJun 30, 2026
Aug 11, 20264Aug 7, 2026
Aug 7, 2026144—
Aug 7, 2026SCHEDULE 13G—
Aug 6, 20268-KAug 6, 2026
Aug 6, 20264Aug 5, 2026
Aug 5, 2026144—
Jul 9, 20264Jul 7, 2026
Jul 7, 2026144—
Jul 7, 20268-KJun 30, 2026
Jul 1, 2026SCHEDULE 13G/A—
Jun 9, 20264Jun 8, 2026
Jun 8, 2026144—
Jun 3, 20264Jun 1, 2026
May 27, 2026144—
May 26, 2026SD—
May 11, 20264May 7, 2026
May 7, 2026144—
May 4, 20263May 4, 2026

About ResMed Inc.

SEC and exchange records
Company
ResMed Inc.
Exchange
XNYS
SEC CIK
943819
Sessions on record
131
Price source
End of day · delayed
Computed
1 Oct, 10:36 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.